Lars Michel
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Heart Failure Treatment and Management
- Cardiac Fibrosis and Remodeling
- Acute Myocardial Infarction Research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 26
- Viral Infections and Immunology Research 3
- Cardiac Fibrosis and Remodeling 3
- Cardiac Valve Diseases and Treatments 2
- Oncology 21
- Cancer Immunotherapy and Biomarkers 17
- Co-authors
- Tienush Rassaf (52 shared papers)Matthias Totzeck (34 shared papers)Raluca Ileana Mincu (17 shared papers)Amir Abbas Mahabadi (17 shared papers)Fadi Al‐Rashid (4 shared papers)Stephan Settelmeier (8 shared papers)Simone Maria Mrotzek (8 shared papers)Dirk Schadendorf (8 shared papers)
- Journals
- European Heart Journal (13 papers)ESC Heart Failure (5 papers)Current Heart Failure Reports (4 papers)Experimental Hematology (3 papers)Clinical Research in Cardiology (3 papers)
- Partner nations
- GermanyUnited StatesHungary
In The Last Decade
Lars Michel
50 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 67
- Cardiology and Cardiovascular Medicine 684
- Oncology 354
- Cancer Research 43
- Hematology 39
- Biophysics 18
Countries citing papers authored by Lars Michel
This map shows the geographic impact of Lars Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Michel more than expected).
Fields of papers citing papers by Lars Michel
This network shows the impact of papers produced by Lars Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Michel. The network helps show where Lars Michel may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Michel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 205 | |
| 2 | 2019 | 133 | |
| 3 | 2021 | 132 | |
| 4 | 2019 | 98 | |
| 5 | 2010 | 86 | |
| 6 | 2018 | 79 | |
| 7 | 2022 | 78 | |
| 8 | 2019 | 66 | |
| 9 | 2020 | 34 | |
| 10 | 2024 | 32 | |
| 11 | 2020 | 26 | |
| 12 | 2023 | 21 | |
| 13 | 2019 | 20 | |
| 14 | 2020 | 18 | |
| 15 | 2019 | 17 | |
| 16 | 2020 | 16 | |
| 17 | 2016 | 15 | |
| 18 | 2016 | 14 | |
| 19 | 2024 | 14 | |
| 20 | 2024 | 14 |
About Lars Michel
Lars Michel is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Molecular Biology, Hematology and Pathology and Forensic Medicine, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (26 papers), Cancer Immunotherapy and Biomarkers (17 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Acute Myeloid Leukemia Research (3 papers), Viral Infections and Immunology Research (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Cardiac Ischemia and Reperfusion (2 papers) and Cardiac Valve Diseases and Treatments (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (684 citations), Oncology (354 citations), Cancer Research (43 citations), Hematology (39 citations) and Biophysics (18 citations). Lars Michel has collaborated with scholars based in Germany, United States and Hungary. Frequent co-authors include Tienush Rassaf, Matthias Totzeck, Raluca Ileana Mincu, Amir Abbas Mahabadi, Fadi Al‐Rashid, Stephan Settelmeier, Simone Maria Mrotzek, Dirk Schadendorf, Yi Fan Lin and Joerg Herrmann. Their work appears in journals such as European Heart Journal, ESC Heart Failure, Current Heart Failure Reports, Experimental Hematology and Clinical Research in Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.